JNJ vs MDT
By Alex · Tickerpine
Johnson & Johnson vs Medtronic plc, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | MDT |
|---|---|---|
| Price | $271.95 | $89.50 |
| Market cap | $655.37B | $114.48B |
| P/E ratio | 31.4 | 21.8 |
| ROE | 25.74% | 10.65% |
| Profit margin | 21.48% | 13.93% |
| Revenue growth | 6.60% | 13.70% |
| Dividend yield | 1.97% | 3.22% |
| Beta | 0.23 | 0.57 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs MDT in plain English
- JNJ is the bigger company — about 5.7× the market cap of MDT.
- MDT is cheaper on earnings (P/E 21.8 vs 31.4).
- JNJ earns a higher return on equity (26% vs 11%).
- MDT is growing revenue faster (14% vs 7%).
- MDT has the higher dividend yield (3.22% vs 1.97%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
MDT return calculator
See what $1,000 in Medtronic plc would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.